Status:
COMPLETED
Acellular Dermal Matrix Allograft Versus Free Gingival Graft
Lead Sponsor:
University of Sao Paulo
Conditions:
Gingiva Atrophy
Gingivitis
Eligibility:
All Genders
18-60 years
Phase:
NA
Brief Summary
The present split-mouth controlled randomized clinical trial aimed to evaluate clinical and histological results of acellular dermal matrix allograft (ADM) compared to autogenous free gingival graft (...
Eligibility Criteria
Inclusion
- absence or deficiency of keratinized tissue (\< 1mm) in two homologous contralateral sites of inferior premolars
- Miller Class I or II gingival recession
- Absence of radiographic bone loss
- Vital tooth or with adequate endodontic treatment
- Root surfaces without caries
- Good oral hygiene (plaque index \< 20%)
Exclusion
- Allergic to penicillin
- Presenting systemic disease that impede surgical procedure
- Smokers
- Pregnancy
- Intake of calcium channel blockers that cause gingival augmentation
Key Trial Info
Start Date :
February 1 1999
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
December 20 2017
Estimated Enrollment :
25 Patients enrolled
Trial Details
Trial ID
NCT03251001
Start Date
February 1 1999
End Date
December 20 2017
Last Update
March 9 2018
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Bauru School of Dentistry
Bauru, São Paulo, Brazil, 17012-901